Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Publications section updated: replaced the 2025 online-ahead-of-print citation with the 2026 J Thorac Oncol article by Chen MF et al.
    Difference
    0.1%
    Check dated 2026-04-03T18:56:29.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-20T05:21:52.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The bottom revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:38:39.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added a new publication citation for Chen MF et al., Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases. J Thorac Oncol. 2025 Oct 23:103505. Removed the earlier print-entry citation (S1556-0864(25)02859-X) in PubMed publications.
    Difference
    0.1%
    Check dated 2026-02-26T15:15:07.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is displayed instead of v3.4.1, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:39:05.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-05T00:34:59.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.